Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,004,598
-$221,657 QoQ
Shares Held
31,697
+4.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#632
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Capital Management, LLC holds $495,472,264 across 11 Drug Manufacturers - General names. GILD ranks #9 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
526,560 | $133,730,443 | |
| 2 | ABBV |
AbbVie Inc.
|
505,318 | $127,158,221 | |
| 3 | PFE |
Pfizer Inc
|
2,703,246 | $65,094,163 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,029,843 | $59,339,553 | |
| 5 | LLY |
ELI LILLY & Co
|
38,507 | $46,186,454 | |
| 6 | AMGN |
Amgen Inc
|
73,921 | $26,768,272 | |
| 7 | MRK |
Merck & Co., Inc.
|
179,565 | $23,074,102 | |
| 8 | NVS |
Novartis AG
|
57,958 | $9,083,177 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,004,598 | 31,697 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,226,255 | 30,324 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,769,836 | 30,714 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,392,937 | 30,567 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,374,882 | 30,440 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,055,649 | 36,195 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $3,617,486 | 39,163 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,228,594 | 38,509 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $845,892 | 12,329 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,263,196 | 17,245 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,070,628 | 13,216 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $958,857 | 12,795 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $921,140 | 11,952 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,003,024 | 12,089 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,020,327 | 11,885 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $778,527 | 12,620 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $609,755 | 9,865 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $666,731 | 11,215 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $817,370 | 11,257 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $785,533 | 11,246 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $783,764 | 11,382 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $699,942 | 10,830 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $642,782 | 11,033 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $701,977 | 11,109 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $874,961 | 11,372 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $792,979 | 10,607 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||